A detailed history of Hemington Wealth Management transactions in Novo Nordisk A S stock. As of the latest transaction made, Hemington Wealth Management holds 218 shares of NVO stock, worth $18,318. This represents 0.0% of its overall portfolio holdings.

Number of Shares
218
Previous 335 34.93%
Holding current value
$18,318
Previous $37,000 51.35%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 29, 2025

SELL
$85.0 - $120.04 $9,945 - $14,044
-117 Reduced 34.93%
218 $18,000
Q3 2024

Nov 12, 2024

BUY
$119.07 - $145.42 $39,888 - $48,715
335 New
335 $37,000
Q4 2023

Jan 26, 2024

BUY
$87.78 - $105.45 $175,560 - $210,900
2,000 New
2,000 $207,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $190B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Hemington Wealth Management Portfolio

Follow Hemington Wealth Management and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hemington Wealth Management, based on Form 13F filings with the SEC.

News

Stay updated on Hemington Wealth Management with notifications on news.